Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients

• Status: Completed
• Trial end date: 2019-07-20
• Target enrollment: 0
• Participant gender: All

Summary

Acne Vulgaris is one of the most common dermatologic diagnoses requiring long-term maintenance therapy. Promising results of oral zinc gluconate in improving acne vulgaris has been described.

A randomized, double blind, placebo-controlled clinical trial was utilized for this study with the objective to assess the efficacy of oral zinc gluconate in the improvement of disease activity in acne vulgaris patients as measured by the inflammatory score and Global Acne Grading System (GAGS) score.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: East Avenue Medical Center, Philippines
• Treatments: Adapalene; Adapalene, Benzoyl Peroxide Drug Combination; Benzoyl Peroxide; Zinc

Criteria

Inclusion Criteria:

• Filipino patients, aged 18-27 years old

• New patients diagnosed with Acne Vulgaris with a Global Acne Grading System score of at least 19

• Able to read and write in English or Tagalog

• Seen at the Dermatology out-patient clinic of East Avenue Medical Center

Exclusion Criteria:

• Patients with other chronic dermatoses or systemic disease

• Taking oral supplements or medications within the past 4 weeks

• Patients who are pregnant or lactating